Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses

Autor: Hulot SL, Korber BT, Pantaleo G, Tartaglia J, Jacobs B, Perdiguero B, Gomez CE, Esteban M, Letvin N, Seaman MS, Haynes B, Santra S

Publikováno v: Retrovirology, Vol 9, Iss Suppl 2, p P288 (2012)

Externí odkaz: https://doaj.org/article/6dc1f3774aaa41c6b65b517080c9b5d3

Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.

Autor: Hulot SL; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Korber B; Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Giorgi EE; Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Vandergrift N; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Saunders KO; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Balachandran H; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Mach LV; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Lifton MA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Pantaleo G; Centre Hospitalier Universitaire Vaudois (CHUV), Université de Lausanne, Lausanne, Switzerland., Tartaglia J; Sanofi-Pasteur, Toronto, Canada., Phogat S; Sanofi-Pasteur, Toronto, Canada., Jacobs B; Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, Arizona, USA., Kibler K; Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, Arizona, USA., Perdiguero B; Centro Nacional de Biotecnologia, Madrid, Spain., Gomez CE; Centro Nacional de Biotecnologia, Madrid, Spain., Esteban M; Centro Nacional de Biotecnologia, Madrid, Spain., Rosati M; National Cancer Institute, Frederick, Maryland, USA., Felber BK; National Cancer Institute, Frederick, Maryland, USA., Pavlakis GN; National Cancer Institute, Frederick, Maryland, USA., Parks R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Lloyd K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Sutherland L; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Scearce R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Letvin NL; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Seaman MS; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Montefiori D; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Liao HX; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Santra S; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA ssantra@bidmc.harvard.edu.

Publikováno v: Journal of virology [J Virol] 2015 Jun; Vol. 89 (12), pp. 6462-80. Date of Electronic Publication: 2015 Apr 08.

Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity.

Autor: Hulot SL; Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Cale EM, Korber BT, Letvin NL

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2011 May 15; Vol. 186 (10), pp. 5663-74. Date of Electronic Publication: 2011 Apr 13.

Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.

Autor: Manuel ER; Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, E/CLS Room 1043, Boston, Massachusetts 02215, USA., Yeh WW, Seaman MS, Furr K, Lifton MA, Hulot SL, Autissier P, Letvin NL

Publikováno v: Journal of virology [J Virol] 2009 Oct; Vol. 83 (19), pp. 10028-35. Date of Electronic Publication: 2009 Jul 29.

RV144 HIV-1 vaccination impacts post-infection antibody responses.

Autor: Mdluli, Thembi^1,2 (AUTHOR), Jian, Ningbo^1,2 (AUTHOR), Slike, Bonnie^1,2 (AUTHOR), Paquin-Proulx, Dominic^1,2 (AUTHOR), Donofrio, Gina^1,2 (AUTHOR), Alrubayyi, Aljawharah^1,2 (AUTHOR), Gift, Syna^1,2 (AUTHOR), Grande, Rebecca^1,2 (AUTHOR), Bryson, Mary^1,2 (AUTHOR), Lee, Anna^1,2 (AUTHOR), Dussupt, Vincent^1,2 (AUTHOR), Mendez-Riveria, Letzibeth^1,2 (AUTHOR), Sanders-Buell, Eric^1,2 (AUTHOR), Chenine, Agnès-Laurence^1,2 (AUTHOR), Tran, Ursula^1,2 (AUTHOR), Li, Yifan^1,2 (AUTHOR), Brown, Eric³ (AUTHOR), Edlefsen, Paul T.⁴ (AUTHOR), O'Connell, Robert⁵ (AUTHOR), Gilbert, Peter⁴ (AUTHOR)

Publikováno v: PLoS Pathogens. 12/8/2020, Vol. 16 Issue 12, p1-29. 29p.